Hycamtin
Active Ingredient(s): TopotecanFDA Approved: * May 28, 1996
Pharm Company: * GLAXOSMITHKLINE
Category: Cancer
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Hycamtin Overview
Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types. After GlaxoSmithKline received final FDA approval for Hycamtin Capsules on October 15, 2007, topotecan became the first topoisomerase I inhibitor for oral use. Contents 1 Uses 1.1 Experimental uses 1.2...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Topotecan
Recent Hycamtin Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Topotecan
- Capsule: 0.25mg, 1mg
- Injection: 1.5mg, 1mg/ml, 3mg/3ml, 4mg/4ml, 4mg/vial
- Solution: 1mg/ml (1mg/ml), 3mg/3ml (1mg/ml), 4mg/4ml (1mg/ml)
NDC Database Records for Hycamtin: (9 results)
Sorted by National Drug Code- 0007-4201 Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline LLC
- 0007-4205 Hycamtin 0.25 mg Oral Capsule by Glaxosmithkline LLC
- 0007-4207 Hycamtin 1 mg Oral Capsule by Glaxosmithkline LLC
- 0078-0672 Hycamtin .25 mg Oral Capsule by Novartis Pharmaceuticals Corporation
- 0078-0673 Hycamtin 1 mg Oral Capsule by Novartis Pharmaceuticals Corporation
- 0078-0674 Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Novartis Pharmaceuticals Corporation
- 12064-000 Hycamtin .25 mg Oral Capsule by Glaxosmithkline Manufacturing Spa
- 12064-001 Hycamtin 1 mg Oral Capsule by Glaxosmithkline Manufacturing Spa
- 12064-002 Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa